• Perrigo agreed to sell its infant formula business to MeridianMade for up to $175 million.
• Terms include $40 million cash at closing, with up to $135 million tied to performance milestones through 2030.
• Closing is expected in the first half of 2027.
• A non-cash impairment charge of $275 million to $375 million is expected in the fourth quarter of 2026.
• The sale is expected to improve margins, reduce future capital spending and sharpen the focus on consumer self-care products.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Perrigo Company plc published the original content used to generate this news brief via PR Newswire (Ref. ID: 202610290900PR_NEWS_USPR_____DE84275) on October 29, 2026, and is solely responsible for the information contained therein.